These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4066634)
41. On the prevention of viral transmitted infections in plasma products. Martin W Dev Biol Stand; 1987; 67():233-6. PubMed ID: 3038637 [TBL] [Abstract][Full Text] [Related]
42. [Mechanical donor plasmapheresis using the Haemonetics Ultralite plasma collection system. 1. Collection of fresh plasma]. Matthes G; Pawlow I; Richter E Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):343-8. PubMed ID: 2475417 [TBL] [Abstract][Full Text] [Related]
44. Plasmcapheresis--principles and practice. Jacob CK J Indian Med Assoc; 2001 Jul; 99(7):364-7. PubMed ID: 11881846 [TBL] [Abstract][Full Text] [Related]
45. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis]. Nazarchuk LV; Fedorovskaia EA Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911 [TBL] [Abstract][Full Text] [Related]
46. Development of an automated plasmapheresis procedure for the harvest of equine plasma in accordance with current good manufacturing practice. Ziska SM; Schumacher J; Duran SH; Brock KV Am J Vet Res; 2012 Jun; 73(6):762-9. PubMed ID: 22620688 [TBL] [Abstract][Full Text] [Related]
47. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume. Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739 [TBL] [Abstract][Full Text] [Related]
48. Standardization of albumin, plasma substitutes and plasmapheresis: proceedings of a symposium organized by the International Association of Biological Standardization and held at the World Health Organization, Geneva, Switzerland, November 10-12, 1980. Dev Biol Stand; 1980; 48():1-323. PubMed ID: 7274551 [No Abstract] [Full Text] [Related]
50. EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS. KLIMAN A; CARBONE PP; GAYDOS LA; FREIREICH EJ Blood; 1964 May; 23():647-56. PubMed ID: 14142503 [No Abstract] [Full Text] [Related]
51. [Plasma pH and anticoagulant solutions used in the plasmapheresis method of blood collection from donors]. Pták J; Novácková L; Stachelová M; Slabík D; Králová S Vnitr Lek; 2000 Feb; 46(2):111-3. PubMed ID: 11048534 [TBL] [Abstract][Full Text] [Related]
52. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment. Bove LL; Bednall T; Masser B; Buzza M Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104 [TBL] [Abstract][Full Text] [Related]
53. Influence of long-term plasmapheresis on blood coagulation. Grgicević D Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088 [TBL] [Abstract][Full Text] [Related]
54. Estimating the cost of expanding an apheresis program. Hart W; Jacobs P; Turner AR Transfusion; 1991; 31(6):538-41. PubMed ID: 1853449 [TBL] [Abstract][Full Text] [Related]
55. The current status of blood fractionation in the United States. Sgouris JT Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014 [No Abstract] [Full Text] [Related]
56. Plasma fractionation in the United States. A review for clinicians. Ness PM; Pennington RM JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885 [No Abstract] [Full Text] [Related]
57. Platelet transfusion procedures. Platelet Transfusion Subcommitte of the Acute Leukemia Task Force. Cancer Chemother Rep 3; 1968 Dec; 1(1):1-12. PubMed ID: 5212270 [No Abstract] [Full Text] [Related]
58. [Epidemiological and serological study on hepatitis C virus infection in plasmapheresis donors]. Sun Y Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Dec; 12(6):327-30. PubMed ID: 1667379 [TBL] [Abstract][Full Text] [Related]